Cyprus vs Lebanon: Share of E. coli infections resistant to cephalosporins
Cyprus
40.5%
in 2022
Lebanon
37.2%
in 2022
Cyprus rank
20th
Lebanon rank
22nd
Share of E. coli infections resistant to cephalosporins over time
- Cyprus
- Lebanon
How they compare
Cyprus currently reports 40.5% against 37.2% in Lebanon, a difference of 3.3%.
That makes Cyprus's figure about 1.1 times Lebanon's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Lebanon ahead.
Cyprus ranks 20th and Lebanon ranks 22nd of 46 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.2% | 50.7% | 21.5% | Lebanon |
| 2020s | 44.4% | 47.9% | 3.5% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Cyprus or Lebanon?
- Cyprus, at 40.5% against 37.2% in Lebanon as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Cyprus and Lebanon?
- 3.3%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Lebanon?
- 6 years are reported by both, from 2017 to 2022.
- How do Cyprus and Lebanon rank globally for share of e. coli infections resistant to cephalosporins?
- Cyprus ranks 20th and Lebanon ranks 22nd of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).